Rhythm Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:RYTM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -40.35 M-23.31 M-26.62 M-25.39 M-44.19 M -119.51 M Cash from investing activities 24.81 M54.03 M-246.35 M30.35 M57.05 M -104.91 M Cash from financing activities 32.5 M-889 K189.3 M-2.95 M-5.4 M 180.06 M Free cash flow -40.35 M-23.31 M-26.62 M-25.39 M-44.19 M -119.51 M

News

Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?

Intel Stock and 3 Other Winners I Found Using Barchart’s High-Octane Stock Screener

The Battle Against Genetic Obesity Just Sent This Biotech Stock Flying

Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Rhythm Stock: The Rare Obesity Platform Is Becoming A Commercial Engine

Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results - Rhythm Pharmaceutical

Rhythm Pharmaceuticals, Inc. (RYTM) Q1 2026 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue Estimates

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth

Analysts Estimate Rhythm Pharmaceuticals, Inc. (RYTM) to Report a Decline in Earnings: What to Look Out for

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?